The Week in Review: Tigermed and Shuangcheng Pharma Complete IPOs
23:43 EDT 18 Aug 2012 | ChinaBio Today
Hangzhou Tigermed Consulting, a clinical-stage CRO, staged an $80 million IPO on Shenzhen’s ChiNext exchange; Hainan Shuangcheng Pharma made its public company debut on the Shenzhen main board, raising $94 million; two China medical research..
Original Article: The Week in Review: Tigermed and Shuangcheng Pharma Complete IPOs
More From BioPortfolio on "The Week in Review: Tigermed and Shuangcheng Pharma Complete IPOs"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
